ENMD - EntreMed Inc.

1.94 0.00 (0.00%)

NasdaqCM: ENMD Stock Quote

Last Trade: 1.94   Day's Range: N/A - N/A
Trade Time: 3:59pm   52wk Range: 0.90 - 5.00
Change: 0.00 (0.00%)   Volume: 0
Prev Close: 1.94   Avg Vol (3m): 59,614
Open: N/A   Market Cap: 23.6M
Bid: N/A x N/A   P/E (ttm): N/A
Ask: N/A x N/A   EPS (ttm): -0.46
1y Target Est: 1.00   Div & Yield: 0.00 (N/A)

NasdaqCM: ENMD Overview

EntreMed, Inc. (EntreMed) is a clinical-stage pharmaceutical company focused on developing focused on developing ENMD-2076, an Aurora A and angiogenic kinase inhibitor for the treatment of cancer. ENMD-2076 is in Phase I studies in advanced cancers, multiple myeloma and leukemia. ENMD-2076 has received orphan drug designation from the United States Food and Drug Administration (FDA) for the treatment of ovarian cancer, multiple myeloma and acute myeloid leukemia (AML).


Members Picking ENMD
Pick
Message Board Posts On ENMD
Message
Comments & Rumors On ENMD
Please sign-in to post a comment, or register for a free SmallCap Network account.
Have something to say about ENMD? Just type something in the box above.
Member Analysis Of ENMD
Analysis
ENMD Research Media
File
Member Articles On ENMD
Article
Member Blog Posts On ENMD
Blog
Other News and Information on ENMD

No Blog Sources. Submit New Ones By Clicking Here.

No Message Board Sources. Submit New Ones By Clicking Here.



Do you know of another great research resource for ENMD that belongs here? Please let us know and provide the URL.

Join the 200,000+ other Members who take full advantage of all the SmallCap Network has to offer: Sign In or Join